You are here
Investigation of the Efficacy and Mechanism of FDA approved Activators of Hypoxic Adaptation in the Metabolic Consequences and Treatment of Parkinson’s Disease
June 1, 2009 to May 31, 2011
GRANT:
Non-FederalFunding Status:
Completed ProjectFunding Agency:
Thomas Hartman FoundationGoals
The major goal of this project is to evaluate the effects of HIF prolyl hydroxylase inhibitors in Parkinson's disease models.
Investigators
Associated
Research Labs:
Ratan Lab